[1] Qureshi K , Abrams GA . Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.Clin Obes, 2016, 6:117-123.
[2] Yoshimoto S , Loo TM , Atarashi K , et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature, 2013, 499:97-101.
[3] Younossi Z M , Stepanova M , Negro F , et al. Nonalcoholic fatty liver disease in lean individuals in the united states. Medicine, 2012, 91:319-327.
[4] Zhu JZ , Zhou QY , Wang YM , et al. Prevalence of fatty liver disease and the economy in China: A systematic review. World J Gastroenterol, 2015,21:5695-5706.
[5] Jiang W , Wu N , Wang X , et al. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci Rep, 2015, 5:8096.
[6] Sabio G , Das M , Mora A , et al. A Stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science, 2008, 322:1539-1543.
[7] Tarantino G , Finelli C . What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? World J Gastroenterol, 2013, 19:3375-3384.
[8] Anderson N , Jürgen Borlak. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.Pharmacol Rev, 2008, 60:311-357.
[9] Janssen AWF , Kersten S . The role of the gut microbiota in metabolic health. FASEB J, 2015, 29:3111-3123.
[10] Flint HJ, Scott KP, Louis P, et al. The role of the gut microbiota in nutrition and health.. Nat Rev Gastroenterol Hepatol, 2012, 9:577-589.
[11] Son G , Kremer M , Hines IN . Contribution of gut bacteria to liver pathobiology. Gastroenterol Res Pract,2010, 2010, 2010:70-80.
[12] Yamada S , Kamada N , Amiya T , et al. Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis. BMC Gastroenterol, 2017, 17:136.
[13] Guerville M , Gaëlle Boudry. Gastro-intestinal and hepatic mechanisms limiting the entry and dissemination of lipopolysaccharide into the systemic circulation. Am J Physiol Gastrointest Liver Physiol, 2016, 311:ajpgi.00098.
[14] Machado M , Cortezpinto H . Diet, microbiota, obesity, and NAFLD: A dangerous quartet. Int J Mol Sci, 2016, 17:481.
[15] Zhu L , Baker SS , Gill C , et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH. Hepatology, 2013, 57:601-609.
[16] Makoto U , Makoto M , Hayato Y . Gut microbiota and host metabolism in liver cirrhosis. World J Gastroenterol, 2015, 21:11597-11608.
[17] Roy TL , Llopis M , Lepage P , et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut, 2013, 62:1787-1794.
[18] Li Z , Yang S , Lin H , et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology, 2003, 37:343-350.
[19] Feng W , Wang H , Zhang P , et al. Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats. Biochim Biophys Acta Gen Subj, 2017, 1861:1801.
[20] Cao Y , Pan Q , Cai W , et al. Modulation of gut microbiota by berberine improves steatohepatitis in high-fat diet-fed BALB/C mice. Arch Iran Med, 2016, 19:197.
[21] Daubioul CA , Horsmans Y , Lambert P , et al. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. Eur J Clin Nutr, 2005, 59:723-726. |
